Lv5
1088 积分 2023-11-29 加入
In vivo generation of chimeric antigen receptor T cells using optimally retargeted and functionalized lentiviral vectors with reduced immune clearance
6小时前
待确认
miRNA cassettes in viral vectors: Problems and solutions
7小时前
已完结
End Group Engineering for Constructing A−D−A Fused‐Ring Photosensitizers with Balanced Phototheranostics Performance
1天前
待确认
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
6天前
已完结
Darwin’s gemmules and extracellular vesicles: A striking resemblance
6天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
6天前
已完结
Clinical Trial to Evaluate BCMA Car-T (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma
15天前
已关闭
Five‐Year Follow‐Up: Tandem CD19 / CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non‐Hodgkin Lymphoma
16天前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
16天前
已完结
皖公网安备34019202002308
